Ethic Inc. Bristol Myers Squibb CO Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ethic Inc. holds 168,380 shares of BMY stock, worth $9.91 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

168,380

Previous 144,145 16.81%

Holding current value

$9.91 Million

Previous $5.99 Million 45.56%

% of portfolio

0.22%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $961,160 - $1.25 Million	24,235 Added 16.81%	168,380 $8.71 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $975,458 - $1.28 Million	-24,235 Reduced 14.39%	144,145 $5.99 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $790,662 - $896,457	-16,479 Reduced 8.91%	168,380 $9.13 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $444,755 - $530,715	9,174 Added 5.22%	184,859 $9.49 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $2.25 Million - $2.51 Million	38,792 Added 28.34%	175,685 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $979,158 - $1.09 Million	15,369 Added 12.65%	136,893 $8.75 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $1.67 Million - $1.89 Million	25,385 Added 26.4%	121,524 $8.42 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $944,202 - $1.12 Million	13,788 Added 16.74%	96,139 $6.92 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $891 - $526,891	6,857 Added 9.08%	82,351 $5.85 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $1.58 Million - $1.74 Million	21,758 Added 40.49%	75,494 $5.81 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $703,884 - $844,020	11,449 Added 27.07%	53,736 $3.92 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $913,747 - $1.07 Million	17,038 Added 67.48%	42,287 $2.64 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $339,872 - $398,116	5,744 Added 29.45%	25,249 $1.49 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $225,228 - $245,273	3,638 Added 22.93%	19,505 $1.3 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $506,763 - $569,959	-8,540 Reduced 34.99%	15,867 $1 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $416,536 - $472,012	7,214 Added 41.96%	24,407 $1.51 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $271,069 - $300,380	-4,720 Reduced 21.54%	17,193 $1.04 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $322,615 - $377,169	5,885 Added 36.72%	21,913 $1.29 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $15,544 - $22,589	335 Added 2.13%	16,028 $893,000
Q4 2019 May 22, 2020	BUY	$49.21 - $64.19 $95,418 - $124,464	1,939 Added 14.1%	15,693 $1.01 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $676,834 - $882,869	13,754 New	13,754 $883,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account